Response to combined treatment in severe obsessive-compulsive disorder: Case report
DOI:
https://doi.org/10.61708/dps51321Keywords:
Obsessive-Compulsive Disorder, cognitive behavioral therapy, selective serotonin reuptake inhibitorsAbstract
Obsessive-Compulsive Disorder is a mental condition that can cause significant dysfunctions in those who suffer from it. We present the case of an adult male with symptoms of obsessions, compulsions and avoidance that limited his functionality. To assess the severity of Obsessive-Compulsive Disorder, the Yale-Brown Obsessive-Compulsive Scale and the behavioral interview were used, while for depressive symptoms, the Beck Depression Inventory was used. At the beginning of treatment, the patient obtained a score of 34 on the Yale-Brown Obsessive-Compulsive Scale (extreme severity) and 40 points on the Beck Depression Inventory (severe). After 16 weeks of participation in a cognitive-behavioral psychotherapy program that included exposure and response prevention therapy, together with the administration of selective serotonin reuptake inhibitors, the level of severity was reduced to mild on both scales (15 and 13 points, respectively). The combined pharmacological and psychotherapeutic treatment was effective in reducing the symptoms associated with the disorder. The challenges associated with the application of exposure and response prevention therapy as a first-line treatment for obsessive-compulsive disorder are discussed, as well as relevant pharmacological aspects and limitations of the study.
Downloads
References
Ruscio A.M., Stein D., Chiu W.T., Kessler R. (2008). The epidemiology of obsessive-compulsive disorder in the National ComorbidiTy Survey Replication. Molecular Psychiatry, 15 (1), 53-63. https://doi.org/10.1038/mp.2008.94 DOI: https://doi.org/10.1038/mp.2008.94
Harvard Medical School (2007). National Comorbidity Survey (NCSSC). https://www.hcp.med.harvard.edu/ncs/ftpdir/table_ncsr_LTprevgenderxage.pdf
Wetterneck C. T., Little T. E., Rinehart K. L., Cervantes M. E., Hyde E., Williams M. (2012). Latinos with obsessive-compulsive disorder: Mental healthcare utilization and inclusion in clinical trials. Journal of Obsessive-Compulsive and Related Disorders, 1(2), 85-97. https://doi.org/10.1016/j.jocrd.2011.12.001 DOI: https://doi.org/10.1016/j.jocrd.2011.12.001
Pontón Y.P., Alvarado M., Tenesaca E.P. (2022). Prevalencia del trastorno obsesivo compulsivo y factores asociados en el cantón Nabón, 2021 (Tesis de grado). Universidad del Azuay. http://dspace.uazuay.edu.ec/handle/datos/12322
Aguilera J. F., Mendoza A. E. (2019). Prevalencia del Trastorno Obsesivo Compulsivo en la población rural del cantón Cuenca (Tesis de grado). Universidad del Azuay. http://dspace.uazuay.edu.ec/handle/datos/9490
Fineberg N. A., Hollander E., Pallanti S., Walitza S., Grünblatt E., Dell’Osso B. M., Albert U., Geller D. A., Brakoulias V., Janardhan Y. C., Arumugham S. S., Shavitt R. G., Drummond L., Grancini B., De Carlo V., Cinosi E., Chamberlain S. R., Loannidis K., Rodriguez C. I. (...) & Menchon J. M., (2020). Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders. International clinical psychopharmacology, 35(4), 173-193. https://doi.org/10.1097/YIC.0000000000000314 DOI: https://doi.org/10.1097/YIC.0000000000000314
Foa E., Liebowitz M., Kozak M., Davies R. N., Campeas R., Martin E. F…& Xin T. (2005). Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. The American Journal of Psychiatry, 162 (1), 151-161. https://doi.org/10.1176/appi.ajp.162.1.151 DOI: https://doi.org/10.1176/appi.ajp.162.1.151
Cottraux J., Mollard E., Bouvard M., Marks I. (1993). Exposure therapy, fluvoxamine or combination treatment in obsessive-compulsive disorder: One-year follow up. Psychiatry Research, 49(1), 63-75. https://doi.org/10.1016/0165-1781(93)90030-K DOI: https://doi.org/10.1016/0165-1781(93)90030-K
Storch E. A., Lewin A. B., Larson M. J., Geffken G. R., Murphy T. K., Geller D. A. (2012). Depression in youth with obsessive-compulsive disorder: clinical phenomenology and correlates. Psychiatry Research, 196(1), 83-9. https://doi-org/10.1016/j.psychres.2011.10.013 DOI: https://doi.org/10.1016/j.psychres.2011.10.013
Janardhan Y. C., Sundar A.S., Narayanaswamy J. & Math S. (2022). Clinical practice guidelines for Obsessive-Compulsive Disorder. Indian Journal of Psychiatry, 59 (Suppl.1), 74-90. https://doi.org/10.4103/0019-5545.196976. DOI: https://doi.org/10.4103/0019-5545.196976
Nezgovorova V., Reid J., Fineberg N. A., Hollander E. (2022). Optimizing first line treatments for adults with OCD. Comprehensive Psychiatry, 115, 1-4. https://doi.org/10.1016/j.comppsych.2022.152305 DOI: https://doi.org/10.1016/j.comppsych.2022.152305
Jacobson N.C., Newman M.G., Goldfried M.R.(2016). Clinical Feedback About Empirically Supported Treatments for Obsessive-Compulsive Disorder. Behavior Therapy, 47(1), 75-90. https://doi.org/10.1016/j.beth.2015.09.003 DOI: https://doi.org/10.1016/j.beth.2015.09.003
American Psychiatric Association (2007). Practice guideline for the treatment of patients with obsessive-compulsive disorder. The American Journal of Psychiatry, 164 (7), 5-53.
Bandelow B., Allgulander C., Baldwin D. S., Costa D., Denys D., Dilbaz N., … & Zohar, J. (2022). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders. The World Journal of Biological Psychiatry, 24(2), 79–117. https://doi.org/10.1080/15622975.2022.2086295 DOI: https://doi.org/10.1080/15622975.2022.2086295
Salkovskis P. (2007). Psychological treatment of obsessive-compulsive disorder. Psychiatry, 6 (6), 229-233. https://doi.org/10.1016/j.mppsy.2007.03.008 DOI: https://doi.org/10.1016/j.mppsy.2007.03.008
Abramowitz J. S. (2006). The Psychological Treatment of Obsessive—Compulsive Disorder. The Canadian Journal of Psychiatry, 51(7), 407–416. https://doi.org/10.1177/070674370605100702 DOI: https://doi.org/10.1177/070674370605100702
Bloch M. H., McGuire J., Landeros-Weisenberger A., Leckman J. F., Pittenger C. (2010). Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Molecular Psychiatry, 15, 850-855. https://doi.org/10.1038/mp.2009.50 DOI: https://doi.org/10.1038/mp.2009.50
Barr L. C., Goodman W. K., Price L. (1993). The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. International Clinical Psychopharmacology, 8 (Suppl 2), 79-82. https://doi.org/10.1097/00004850-199311002-00011 DOI: https://doi.org/10.1097/00004850-199311002-00011
Wetterneck C., Leonard R. C., Adams T., Riemann B., Grau P., Franklin M. (2020). The effects of depression on the treatment of OCD in a residential sample. Bulletin of the Menninger Clinic, Supplement A, 12-33. https://doi.org/10.1521/bumc.2020.84.suppA.12 DOI: https://doi.org/10.1521/bumc.2020.84.suppA.12
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Copyright: © Los autores. Publicado por Gaceta Médica JBG.
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
